Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

NCT03458559 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

402

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic to Bone

Interventions

DRUG: Radium-223 chloride
DRUG: Rhenium-188-HEDP

Sponsor

Amsterdam UMC, location VUmc